Background: Systemic Lupus Erythematosus (SLE) is a complex chronic immunological disease characterized by increased B cell activity and altered T cell function. Objective: To investigate relationship between T lymphocyte subsets and cortisol with the disease activity of systemic lupus erythematosus patients in North India.
+
/CD8 + T cell and low level of serum cortisol were found in the patients with SLE. The ratio of CD4 + /CD8 + T cell was inversely correlated with systemic lupus erythematosus disease activity index (SLEDAI) score and erythrocyte sedimentation rate (ESR). A positive correlation was observed between CD8 + T cells and SLEDAI score. Furthermore, CD8 + T cells were positively correlated with ESR in the patients with SLE. Conclusion: The results showed that low level of cortisol and high percentage of CD8 + T cells in the lymphocytes could be actively involved in the pathogenesis of SLE.
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+ T cell ratio, cortisol, systemic lupus erythematosus, T-cell activation S ystemic lupus erythematosus (SLE) is a chronic infl ammatory autoimmune disease of unknown aetiology, characterised by arthritis, cutaneous rash, vasculitis, involvement of central nervous system, renal and cardiopulmonary manifestations 1 . Due to loss of self-tolerance there is persistence of autoreactive B and T lymphocyte in SLE 2 . This leads to both systemic and organ-specifi c autoimmunity. The activation of autoreactive T lymphocytes leads to the abnormalities of CD4 + and CD8 + T cells, their numbers and also engenders the autoantibody production characteristic of SLE 3, 4, 5 . Previous studies have found either normal or increased or decreased levels of CD8+ T cells and a decrease in CD4 + T cells, with a consequent decrease of the CD4 + /CD8 + T cell ratio in SLE patients 5, 6, 7 . However, the mechanism of the induction of CD4 + T cell abnormality and its relationship with CD8 + T cell and clinical features of SLE is still not clear. The circulating lymphocyte ratios have been known to be markedly affected by corticosteroids, an anti-infl ammatory hormone, in patients with SLE 8 . The reduced level of cortisol has been found to increase infl ammation in the patients with SLE 9 . However, role of cortisol in relation to the T lymphocytes subsets and pathogenesis of SLE is yet to be investigated.
using the 1982 American Rheumatism Association revised criteria 10 . Disease activity was determined by using SLE Disease Activity Index (SLEDAI) score 11 . The study protocol was approved by the Institute Ethics Committee, Postgraduate Institute of Medical Education and Research, Chandigarh, India and informed consent was obtained from all the patients and controls (healthy subjects). All the patients enrolled in the present study were non-smoker and non-alcoholic.
Blood Samples
Venous blood samples were obtained from patients and healthy controls. Samples were collected into plain and heparinised vacutainers (Becton Dickinson, USA). Samples from plain vacutainers were left to clot, serum was separated, aliquoted and used for estimation of cortisol. Heparinised blood samples were used for the isolation of peripheral blood mononuclear cells (PBMC) for the determination of percentage of CD4 + and CD8 + T cells.
Determination of CD4
+ and CD8 + T cells Peripheral blood mononuclear cells (PBMC) were freshly isolated from heparinised venous blood by Ficoll-Hypaque (Sigma-Aldrich, USA) density gradient centrifugation (400 x g) for 30 minutes. After washing with isotonic phosphate buffered saline solution, cells were enumerated. The cell suspension was adjusted to the concentration of 1 x 10 6 / ml in RPMI 1640 (Sigma Aldrich, USA), supplemented with 10% heatinactivated fetal calf serum (Sigma Aldrich, USA). Twenty microlitres of mouse anti-human anti-CD4-FITC (BD Bioscience) and 20μl of mouse anti-human anti-CD8-APC (Immunostep, Spain) were added and incubated in the dark at 4 o C for one hour. After washing twice with PBS, cells were fi xed with 1% paraformaldehyde. Negative controls were performed simultaneously using FITC-labelled mouse anti-human IgG1 mAb (BD Bioscience) and APC-labelled mouse anti-human IgG1 mAb (BD Bioscience). Cells were acquired and analysis was performed on FACS-Calibur (Becton Dickinson, San Jose, CA, USA) using Cell Quest software (TreeStar, San Carlos, CA, USA).
Determination of serum cortisol
Serum cortisol level was measured by a commercially available enzyme linked immunosorbent assay (ELISA) (Immuno-Technology & Steroid Lab, India). Assay was performed according to manufacturer's instruction. The sensitivity of the kit was 0.28 μg/dl. Briefl y, serum samples and standards were incubated in the anti-cortisol antibody coated wells with horse radish peroxidase-cortisol (HRP-cortisol) conjugate. After incubation, the liquid contents of the wells were decanted and the wells were washed with wash buffer to remove the unbound enzyme conjugates. The bound enzyme activity was measured by developing coloured product from colourless substrate (TMB/H 2 O 2 solution) after incubation at 450 nm. The levels of serum cortisol were determined by comparison with that of standard curve of cortisol.
Statistical analysis
Statistically signifi cant differences were determined using the Student's paired t-test. Correlation analyses were performed using two-tailed Spearman's rank correlation. Analyses were performed using GraphPad Prism v.5.00.288 for Windows (GraphPad Software, San Diego,CA). P values less than 0.05 were considered signifi cant.
Results
The study included 30 patients with SLE (27 females, 3 males) with mean age of 27.50 ± 7.48 years and the control group consisted of 30 healthy volunteers (27 females, 3 males) with mean age of 26.73 ± 5.37 years. Disease activity was determined by using SLE Disease Activity Index (SLEDAI) score (maximum score of 105)
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: Mild score <10; Moderate score 10-20; Severe score >20. Three patients had moderate SLEDAI score while the rest 27 had a SLEDAI score >20 indicating severity of SLE in the present study. The mean SLEDAI Score of the patients with SLE were 38.90 ± 3.31. The levels of ESR, C3 and C4 were 50.63 ± 22.25 (0 -20 mm/hr), 56.93 ± 18.62 (50-120 mg/dl) and 27.39 ± 12.934 (20-50 mg/dl) respectively. Out of 16 patients showing low serum levels of C3 and C4, 5 of them had nephritis. The demographic and clinical characteristics of SLE patients and healthy controls are summarized in the Table 1 and Table 2 respectively.
CD4
+ and CD8 + T cells in PBMC The percentage of T lymphocyte subsets in the PBMC of SLE patients and healthy controls are shown in the Table 3 . A signifi cant decrease in the percentage of CD4 + T cells was found in patients with SLE as compared to healthy controls (P<0.001) while an increase in the percentage of CD8 + T-cells was found in patients with SLE as compared to healthy controls (P<0.001). Furthermore, a considerable decrease in CD4 + /CD8 + T cells ratio was found in patients with SLE compared to the healthy controls (P<0.001).
Serum cortisol
To appraise the role of cortisol in the activation of T cells, the serum cortisol level was determined. A noteworthy decrease in the level of serum cortisol was found in patients with SLE as compared to healthy controls (P<0.001).
Correlation studies
To evaluate the relation of T cells and low serum cortisol in the pathogenesis of SLE, correlations among CD4 + , CD8 + T cells, serum cortisol, C3, C4, ESR and SLEDAI score was studied. As shown in Table 4 , negative correlation was observed between CD4 + T cells (r = -0.3931, P< 0.05) (Fig 2a) and CD4 + /CD8 + T cell ratio (r = -0.5594, P< 0.01) (Fig 2c) with SLEDAI score in the patient with SLE. Positive correlations was observed between CD8 + T cells and SLEDAI score (r =0.4748, P<0.01) (Fig 2b) and between CD8 + T cells and ESR (r =0.5926, P<0.001) (Fig 2e) in patients with SLE. A negative correlation between CD8 + T cells and C4 (r = -0.3631, P<0.05) (Fig 2d) was found to exist. The CD4 + /CD8 + T cell ratio showed a negative correction with ESR (r = -0.4687, P<0.01) (Fig 2f) . + T cell ratio in patients with active SLE. This was especially true in patients with severe lupus nephritis 6, 7 . The present study showed, an increment in CD8 + T cell numbers and a decline in CD4 + T cells, with a consequent reduction in CD4 + /CD8 + T cell ratio in patients with SLE (Table  3) . Similar result has been reported in SLE patients 19, 20 .
Mclnerney et al
15 showed that 45% of the SLE patient population had markedly depressed CD4 T cell levels and signifi cantly low CD4/CD8 T cell ratios while 21, 22 showed that the removal of HLA-DR+ CD8 + T cells and loss of the factors derived from CD8 + T cells lead to the normalization of IL-2 production in the CD4 + T cells in SLE patients. This also supports the hypothesis that the activated CD8 + T cell is involved in the pathogenesis of SLE. The levels of complement proteins C3 and C4 concentration have also been found to be low in 16 patients with SLE which is similar to the study of Hussain et al 23 A signifi cant negative correlation was found between CD8 + T cells and C4 in the patients with SLE. This result suggests that activated CD8 + T cells may be involved in the alteration of complementary pathway in SLE patients.
The circulating lymphocyte has been markedly affected by corticosteroids in patients with SLE 8, 13 . The low serum levels of cortisol is thought to have a proinfl ammatory role 24 and proved to be a therapeutic alternative in SLE 25 . Zietz et al 26 reported that serum cortisol is reduced relative to the degree of systemic infl ammation in SLE and condition become severe when the disease persists over a long period of time (over weeks). In the present study, a signifi cantly reduced level of cortisol was found in SLE patients compared to controls. This result is supported by the study of Straub et al. in SLE patients 27 . Straub et al demonstrated that low level of serum cortisol is not due to renal clearance in patients with SLE. Inadequate production of cortisol may be due to infl ammation induced reduction of adrenal steroidogenesis 28 . Judd et al 28 demonstrated in adrenocortical cells that proinfl ammatory cytokines such as a tumour necrosis factor (TNF) inhibit important enzyme steps of steroidogenesis. No signifi cant correlation was found to exist between cortisol and T lymphocyte subsets in SLE patients and healthy controls. However, the correlation between cortisol and SLEDAI score was found to be negative, though not very signifi cant in patients with SLE. This relation suggests that low level of cortisol may be involved in the disease activity in SLE.
Conclusion
The present study and those reported by other workers suggest that changes of T cell phenotype and CD8 + T cells activation may play an important role in the induction of autoimmunity in SLE. Altered T lymphocyte subsets and low cortisol affect clinical features of disease. Improvement of CD4 + /CD8 + T cell ratio may indicate control of disease, while abnormal CD4 + /CD8 + T cell ratio suggest deterioration or relapse in the clinical features of SLE.
